American Heart Journal
Volume 144, Issue 5 , Pages 760-768, November 2002

A meta-analysis of the angiotensin-converting enzyme gene polymorphism and restenosis after percutaneous transluminal coronary revascularization: Evidence for publication bias☆☆

Leiden and Utrecht, The Netherlands

From the Departments of aCardiology and bMedical Statistics, Leiden University Medical Center, Leiden, and the cInteruniversity Cardiology Institute of the Netherlands (ICIN), Utrecht, the Netherlands

Received 16 July 2001; accepted 11 January 2002.

Abstract 

Background The insertion/deletion polymorphism of the gene encoding angiotensin-converting enzyme is a controversial risk factor for restenosis after percutaneous transluminal coronary revascularization in patients. Genetic association studies addressing this issue are frequently hampered by insufficient power. Therefore, we conducted a meta-analysis of this association, taking into account the possibility of publication bias. Methods We used the MEDLINE database and reviewed citations in relevant articles to identify 12 studies. Information on the design of the studies, the detailed genotype distribution, the angiographic follow-up rate, and the restenosis rate were categorized by use of a standardized protocol. Results Overall, DD (deletion-deletion) homozygotes had a higher restenosis risk than II (insertion-insertion) carriers (odds ratio 1.22, 95% CI 1.04-1.44, P < .05). However, the published studies were significantly heterogeneous, especially those addressing in-stent restenosis. Smaller studies tended to have positive results more frequently, which is characteristic of publication bias. Correcting for publication bias, we estimated the odds ratio to be 1.15 (95% CI 0.98-1.32, not significant). None of the published studies met all rules of genetic epidemiology. Conclusion We conclude that a clinically significant association of the angiotensin-converting enzyme polymorphism with restenosis after percutaneous transluminal coronary revascularization in patients is unlikely. This meta-analysis provides evidence that the pooled estimate based on published literature, which favors an association, is distorted by publication bias. Hence, screening for this mutation in clinical practice is not justified. Future research should preferentially focus on gene-gene interaction and comply with the rules of genetic epidemiology. (Am Heart J 2002;144:760-8.)

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by grant 99.210 from the Netherlands Heart Foundation, and a grant from the Interuniversity Cardiology Institute of the Netherlands.

☆☆ Reprint requests: J. W. Jukema, MD, PhD, FESC, FACC, Leiden University Medical Center, Department of Cardiology, C5-P, PO Box 9600, 2300 RC Leiden, The Netherlands.

 E-mail: J.W.Jukema@lumc.nl

PII: S0002-8703(02)00183-7

doi:10.1067/mhj.2002.125509

Refers to article:

  • Angiotensin-converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: Identifying the guideposts for navigating the genetics landscape

    William E. Kraus, Elizabeth R. Hauser
    American Heart Journal November 2002 (Vol. 144, Issue 5, Pages 747-749)

American Heart Journal
Volume 144, Issue 5 , Pages 760-768, November 2002